125 related articles for article (PubMed ID: 24332712)
1. [Clostridium difficile infection due to ribotype 027: description of an imported case in Spain].
Muñoz-Vélez M; García-Bujalance S
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):542-3. PubMed ID: 24332712
[No Abstract] [Full Text] [Related]
2. Clostridium difficile ribotype 027 arrives in Hong Kong.
Cheng VC; Yam WC; Chan JF; To KK; Ho PL; Yuen KY
Int J Antimicrob Agents; 2009 Nov; 34(5):492-3. PubMed ID: 19464857
[No Abstract] [Full Text] [Related]
3. Imipenem Resistance in Clostridium difficile Ribotype 017, Portugal.
Isidro J; Santos A; Nunes A; Borges V; Silva C; Vieira L; Mendes AL; Serrano M; Henriques AO; Gomes JP; Oleastro M
Emerg Infect Dis; 2018 Apr; 24(4):741-745. PubMed ID: 29553322
[TBL] [Abstract][Full Text] [Related]
4. Different ribotypes in community-acquired Clostridium difficile.
Bignardi GE; Settle C
J Hosp Infect; 2008 Sep; 70(1):96-8. PubMed ID: 18511151
[No Abstract] [Full Text] [Related]
5. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
[TBL] [Abstract][Full Text] [Related]
6. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
Freeman J; Vernon J; Morris K; Nicholson S; Todhunter S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
[TBL] [Abstract][Full Text] [Related]
7. Identification of Clostridium difficile ribotype 027 for the first time in Mainland China.
Wang P; Zhou Y; Wang Z; Xie S; Zhang T; Lin M; Li R; Tan J; Chen Y; Jiang B
Infect Control Hosp Epidemiol; 2014 Jan; 35(1):95-8. PubMed ID: 24334809
[No Abstract] [Full Text] [Related]
8. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
Poilane I; Fantinato C; Cruaud P; Collignon A
Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
[TBL] [Abstract][Full Text] [Related]
9. Fulminant colitis from Clostridium difficile infection, the epidemic strain ribotype 027, in Japan.
Nakamura I; Yamaguchi T; Tsukimori A; Sato A; Fukushima S; Mizuno Y; Matsumoto T
J Infect Chemother; 2014 Jun; 20(6):380-3. PubMed ID: 24726377
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of a multiplex real-time PCR to predict Clostridium difficile ribotype 027.
Barra-Carrasco J; Hernández-Rocha C; Miranda-Cárdenas C; Álvarez-Lobos M; Guzmán Durán AM; Paredes-Sabja D
Anaerobe; 2013 Aug; 22():115-7. PubMed ID: 23603384
[No Abstract] [Full Text] [Related]
11. Molecular epidemiology of Clostridium difficile for clinical practice.
Tschudin-Sutter S
Swiss Med Wkly; 2014; 144():w13995. PubMed ID: 25207831
[TBL] [Abstract][Full Text] [Related]
12. First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland.
Pituch H; Bakker D; Kuijper E; Obuch-Woszczatyński P; Wultańska D; Nurzyńska G; Bielec A; Bar-Andziak E; Łuczak M
Pol J Microbiol; 2008; 57(3):267-8. PubMed ID: 19004250
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
Kuijper EJ; van den Berg RJ; Debast S; Visser CE; Veenendaal D; Troelstra A; van der Kooi T; van den Hof S; Notermans DW
Emerg Infect Dis; 2006 May; 12(5):827-30. PubMed ID: 16704846
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea.
van Steenbergen J; Debast S; van Kregten E; van den Berg R; Notermans D; Kuijper E
Euro Surveill; 2005 Jul; 10(7):E050714.1. PubMed ID: 16785657
[No Abstract] [Full Text] [Related]
15. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.
Huang H; Weintraub A; Fang H; Nord CE
Scand J Infect Dis; 2009; 41(2):158-9. PubMed ID: 18846478
[No Abstract] [Full Text] [Related]
16. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
[TBL] [Abstract][Full Text] [Related]
17. First isolation of Clostridium difficile PCR ribotype 027 in Finland.
Lyytikäinen O; Mentula S; Könönen E; Kotila S; Tarkka E; Anttila VJ; Mattila E; Kanerva M; Vaara M; Valtonen V
Euro Surveill; 2007 Nov; 12(11):E071108.2. PubMed ID: 18005648
[No Abstract] [Full Text] [Related]
18. The epidemiology of Clostridium difficile in Scotland.
Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile ribotype 027-associated disease in children with norovirus infection.
Lukkarinen H; Eerola E; Ruohola A; Vainionpää R; Jalava J; Kotila S; Ruuskanen O
Pediatr Infect Dis J; 2009 Sep; 28(9):847-8. PubMed ID: 19636284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
